RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Nephrology | West Windsor, NJ | $124.07 | 6 |
| , DO | Nephrology | Brick, NJ | $123.01 | 5 |
| , M.D | Nephrology | Teaneck, NJ | $121.97 | 6 |
| , M.D | Nephrology | Teaneck, NJ | $121.97 | 6 |
| , D.O | Internal Medicine | Valhalla, NY | $117.14 | 5 |
| , MD | Nephrology | Somerset, NJ | $117.09 | 6 |
| , D.O | Nephrology | Monroe, NJ | $116.08 | 5 |
| , D.O | Nephrology | Brick, NJ | $114.15 | 5 |
| , MD | Nephrology | Dayton, OH | $113.15 | 7 |
| Kendall From | — | Alexandria, LA | $113.10 | 9 |
| , M.D | Specialist | Brick, NJ | $111.85 | 5 |
| Patrick Martinucci | — | Youngstown, OH | $109.76 | 5 |
| , M.D | Internal Medicine | Warren, MI | $109.13 | 6 |
| , DO | Nephrology | Eatontown, NJ | $108.33 | 5 |
| , MD | Nephrology | Alexandria, LA | $105.27 | 8 |
| , M.D | Internal Medicine | Dallas, TX | $103.95 | 5 |
| , MD | Nephrology | Dallas, TX | $103.95 | 5 |
| , M.D | Nephrology | Cincinnati, OH | $100.17 | 7 |
| , M.D | Nephrology | Monroe, LA | $99.97 | 7 |
| , M.D | Nephrology | Kerrville, TX | $99.59 | 7 |
| , D.O | Nephrology | Brick, NJ | $97.80 | 4 |
| Robert Rigolosi | — | Teaneck, NJ | $97.08 | 5 |
| , DO | Nephrology | South River, NJ | $93.40 | 4 |
| , M.D | Nephrology | Long Branch, NJ | $92.11 | 4 |
| , MD | Nephrology | Memphis, TN | $90.45 | 4 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).